Preparation and Evaluation of the Fully Humanized Monoclonal Antibody GD-mAb Against Respiratory Syncytial Virus
Respiratory syncytial virus (RSV) is the major cause of pulmonary and bronchial inflammation in infants, young children, and immunocompromised adults, but therapeutic options to control RSV are limited. In the present study a single chain antibody against RSV (GD-scFv) was screened using phage displ...
Main Authors: | Puyuan Tian, Yuqing Wang, Hui Liu, Yulu Yang, Xiaoli Wu, Hua Wei, Tingtao Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-07-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fcimb.2019.00275/full |
Similar Items
-
Epidemiology and prevention of respiratory syncytial virus infections in children in Italy
by: Chiara Azzari, et al.
Published: (2021-10-01) -
Mutation of Respiratory Syncytial Virus G Protein’s CX3C Motif Attenuates Infection in Cotton Rats and Primary Human Airway Epithelial Cells
by: Binh Ha, et al.
Published: (2019-07-01) -
Maternal Effects of Respiratory Syncytial Virus Infection during Pregnancy
by: Sarahn M. Wheeler, et al.
Published: (2015-11-01) -
Morbidity and mortality of respiratory syncytial virus infection in hospitalized adults: Comparison with seasonal influenza
by: Alaa Atamna, et al.
Published: (2021-02-01) -
Prevention of Pediatric Respiratory Syncytial Virus Lower Respiratory Tract Illness: Perspectives for the Next Decade
by: Sofia S. Aranda, et al.
Published: (2019-05-01)